AI may just be the prescription for pharmaceutical's future

In a recent Infosys multi-market research study, 'Amplifying Human Potential Toward Purposeful AI', pharmaceutical and life sciences emerged as the leader in the journey to AI maturity. For several years now, the pharmaceutical sector has been quietly using AI and automation technologies for clinical trials, drug analysis, and to accelerate the process of launching products. Artificial intelligence is also making a huge contribution beyond just making operations more efficient. One example is improving melanoma survival rates by identifying fatal blotches much earlier and more accurately by using technology to amplify human capability. Detecting this deadly cancer early makes a huge difference--survival rates can go as high as 98 percent from as low as 16 percent if detection happens before the disease progresses to the lymph nodes. Today, the Translational Genomics Research Institute's Center for Rare Childhood Disorders is running extremely complex algorithms to analyze massive quantities of genetic and molecular data to diagnose medical conditions and develop personalized treatments.